Search research articles
Contact Us
Filters
Showing results (11-20 of 130) with videos related to
Page
of 13
Sort By:
Chemical Research in Toxicology
|
April 22, 2008
Beyond poisons and problems: toxicology in Italy
Paolo Preziosi, Giorgio Minotti
Photochemistry and Photobiology
|
August 16, 2013
Development of a tumor-specific photoactivatable doxorubicin prodrug
Albert W Girotti, Giorgio Minotti
Journal of Cancer Research and Clinical Oncology
|
November 6, 2021
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma
Pier Luigi Zinzani, Giorgio Minotti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2021
Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to Cardioprotection
Robert S Benjamin, Giorgio Minotti
Cardiovascular Toxicology
|
July 27, 2007
Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes
Luca Gianni, Emanuela Salvatorelli, Giorgio Minotti
Expert Opinion on Drug Safety
|
July 13, 2017
Cancer drugs and QT prolongation: weighing risk against benefit
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemical Research in Toxicology
|
July 16, 2016
Rethinking Drugs from Chemistry to Therapeutic Opportunities: Pixantrone beyond Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 2007
Doxorubicin degradation in cardiomyocytes
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Future Cardiology
|
August 5, 2015
Managing anthracycline-induced cardiotoxicity: beginning with the end in mind
Emanuela Salvatorelli, Pierantonio Menna, Giorgio Minotti
Acta Haematologica
|
October 20, 2020
The Reality of Pixantrone in Real Life
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Page
of 13
Search research articles
Search
Showing results (11-20 of 130) with videos related to
Sort By:
Page
of 13
Chemical Research in Toxicology
|
April 22, 2008
Beyond poisons and problems: toxicology in Italy
Paolo Preziosi, Giorgio Minotti
Photochemistry and Photobiology
|
August 16, 2013
Development of a tumor-specific photoactivatable doxorubicin prodrug
Albert W Girotti, Giorgio Minotti
Journal of Cancer Research and Clinical Oncology
|
November 6, 2021
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma
Pier Luigi Zinzani, Giorgio Minotti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2021
Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to Cardioprotection
Robert S Benjamin, Giorgio Minotti
Cardiovascular Toxicology
|
July 27, 2007
Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes
Luca Gianni, Emanuela Salvatorelli, Giorgio Minotti
Expert Opinion on Drug Safety
|
July 13, 2017
Cancer drugs and QT prolongation: weighing risk against benefit
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemical Research in Toxicology
|
July 16, 2016
Rethinking Drugs from Chemistry to Therapeutic Opportunities: Pixantrone beyond Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 2007
Doxorubicin degradation in cardiomyocytes
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Future Cardiology
|
August 5, 2015
Managing anthracycline-induced cardiotoxicity: beginning with the end in mind
Emanuela Salvatorelli, Pierantonio Menna, Giorgio Minotti
Acta Haematologica
|
October 20, 2020
The Reality of Pixantrone in Real Life
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Page
of 13